Intravenous Caffeine Citrate versus Magnesium Sulphate for Pain control of Acute Migraine Headache
- Conditions
- Common Migraine.Migraine without aura [common migraine]
- Registration Number
- IRCT2016061315640N2
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Moderate to severe pain (pain score>4) in ages 18-60 year old; with History of at least five attacks lasts 4 to 72 hours (untreated or unsuccessfully treated) and headache has at least two of the following characteristics: Unilateral location, Pulsating quality, Moderate to severe pain intensity, Aggravation by or causing avoidance of routine physical activity; At least one of the following during headache: Nausea or vomiting (or both), Photophobia and phonophobia; Not attributable to another disorder
Exclusion criteria: History of ... Arrhythmia; Ischemic heart disease; Hypertension; Peptic ulcer disease; Inflammatory bowel disease; Obsessive disorder; Pregnancy; Breast feeding period; Homeostasis disorder; Renal failure; Hepatic failure; Sleep disorder
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: 30 min, 1 and 2 hour after drug administration. Method of measurement: Visual Analog Scale (VAS).
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: from starting drug administration to 2 hours after end. Method of measurement: Serial physical exam.